clinicaltrialsarena3h
Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials
The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.
clinicaltrialsarena19h
ProJenX and Unlearn partner to use AI-generated digital twins in ALS trial
ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...
clinicaltrialsarena10h
Longboard Pharmaceuticals begins Phase III Dravet syndrome trial
Longboard Pharmaceuticals has commenced the Phase III DEEp SEA Study of bexicaserin for treating seizures in Dravet syndrome ...
clinicaltrialsarena19h
US’ first self-administered flu vaccine could increase accessibility and uptake
FluMist is a live-attenuated influenza vaccine. Credit: PeopleImages.com – Yuri A via Shutterstock. The US Food and Drug ...
clinicaltrialsarena7h
AbbVie’s $8.7bn Parkinson’s disease drug shines in Phase III trial
The Phase III TEMPO-1 trial enrolled 529 adults, between the ages of 40 and 80, diagnosed with Parkinson’s for less than three years.